ARTICLES
(in a quartz cuvette) were exposed to the light of a Hg lamp (100 W) at a distance
of 25 cm. Photocleavage of Nvoc was analysed by RP-HPLC coupled to mass
spectrometry, revealing conversion to deprotected (uncaged) K-peptide with a
different retention time and the expected loss in molecular mass (Supplementary
Figs S2 and S3). To study the kinetics of photolysis, illumination was performed
for different time points (0,5,8,10,15,20 and 40 s) and assessed by analytical
HPLC. Photolysis efficiency was determined on the basis of area ratios of
peaks of the deprotected peptide [1] to the sum of caged peptide [10] and
deprotected peptide [1].
MSC culture and multicellular spheroid formation. MSCs previously isolated
from human placenta35 were cultured in DMEM with Glutamax supplemented
with 1 mM sodium pyruvate, HEPES at pH 7.5, 5% penicillin/streptomycin and
10% fetal calf serum. Cells were used between passages 7 and 16. Multicellular
spheroids were formed from 15×103 cells ml−1 using a hanging-drop technique
(30 µl droplets) in serum-free DMEM with 20% methocel derived from methyl
cellulose (Sigma) as described previously36. Spheroids were collected after overnight
incubation and washed once in serum-free DMEM medium.
Preparation of PEG hydrogels for 3D cell culture. MMP-sensitive PEG hydrogels
were formed as described previously23 through Michael-type addition from two
aqueous precursors containing 4arm-PEG–vinylsulphone (20 kDa) and the MMP
substrate peptide GCRDGPQG↓IWGQDRCG (↓ indicates cleavage site, MW
1773 g mol−1) at equimolar ratio and a final concentration of 3.4% (w/v). Gelation
was performed in the presence of MSC spheroids in 0.1 M HEPES at pH 7.9 and
13% medium at 37 ◦C for 35 min. Caged K-peptide (1 mM) was incorporated in
hydrogels. Gels (10 µl precursor solutions) were cast on µ-slide angiogenesis (ibidi,
Germany). The obtained thin hydrogel layers were immersed in medium to swell
to equilibrium at 37 ◦C.
FXIIIa-mediated crosslinking in solution. FXIIIa was used at 1 U ml−1 for
enzyme-catalysed crosslinking of the two substrates AcFKGGERCG-NH2 (100 µM)
and NQEQVSPLERCG-NH2 (100 µM) in 100 µl of reaction buffer containing
50 mM CaCl2, 50 mM Tris at pH 7.6 and 1 mM dithiothreitol. Reactions were
conducted for 45 min at room temperature and stopped by the addition of 50 µl
0.1% trifluoroacetic acid in H2O, and kept on ice before performing analytical
RP-HPLC (C18-column, Symmetry, Waters).
Preparation of thin PEG hydrogel films. PEG hydrogels (5% w/v) were
prepared by Michael-type addition from two aqueous precursors containing
8arm-PEG–vinylsulphone and 4arm-PEG–thiol (ref. 34). Gelation was performed
in 0.3 M HEPES at pH 7.9 at 37 ◦C for 20 min. Incorporation of 1 mM caged
K-peptide through thiols of its cysteine residue rendered hydrogels photosensitive.
Hydrogels were cast between 3-mercaptopropyl-trimethoxylsilane-treated glass
slides and hydrophobic, siliconized glass slides (Sigmacote, SL-2) using 100 µm
spacers. The obtained thin hydrogel layers were immersed in water to allow
overnight swelling at 4 ◦C.
FXIIIa-mediated biomolecule tethering to hydrogels in three dimensions.
Laser-treated hydrogels were immersed for 90 min in FXIIIa-labelling solution
(2 U ml−1 FXIIIa, 10 mM CaCl2, 10 mM HEPES at pH 7.5 in serum-free DMEM
medium) with peptides or recombinant proteins containing the exogenous FXIIIa
substrate NQEQVSPL as a Q-peptide at the N terminus. The crosslinking reaction
was stopped by washing with PBS followed by serum-free DMEM for several
minutes. This procedure was repeated twice with subsequent overnight washing
at 37 ◦C and 5% CO2.
Laser-assisted hydrogel patterning. An upright point-scanning confocal
microscope (Zeiss, 710 LSM) equipped with a 405 nm diode laser (30 mW) and
with W N-Achroplan ×20/0.5 or EC Plan-Neofluar ×10/0.30 objectives was
employed for local illumination of gels. The bleaching mode and user-defined
ROI scanning option of the microscope software (ZEN2009) allowed precisely
controlled arbitrary patterns in xyz. Precise control of specific laser intensities
assigned to each ROI allowed the generation of biochemical gradients. For example,
step-wise gradients were obtained by aligning seven contacting rectangular ROIs
(100 µm width), each of which had assigned a different assigned laser intensity
(100–80–60–40–20–10–5% of the maximal laser power). The time of laser
irradiation was approximately 2.5 min, equal to the sum of 100 iterations of laser
scanning. Continuous gradients were obtained by decreasing the laser power
(18–5% of the maximal power) and by choosing smaller patterns (rectangles of
25 µm in width). In this case, the time of laser irradiation was approximately
1.5 min, equal to the sum of 200 iterations of laser scanning.
3D MSC invasion in patterned hydrogels. The Q-peptide-modified RGD peptide
NQEQVSPL-RGDSPERCG was functionalized with a maleimide-functionalized
Alexa Fluor 488 (A-10254, Invitrogen), and 150 µM of the peptide was added to the
labelling solution and immobilized as described above. After overnight washing,
hydrogels were immersed in DMEM supplemented with serum and 100 ng ml−1
recombinant human PDGF-BB (PreproTech) to stimulate cell migration. The
same procedures were used for the recombinant fibronectin type III repeat 9–10
fragment (specifically referred to elsewhere as FNIII9*–10; ref. 24) (21 kDa,
130 µM) and a recombinant PDGF-BB variant (20 ng ml−1) bearing exogenous
Q-peptides (production described in Supplementary Information). In the latter
case, hydrogels were rendered cell-adhesive by conjugating 30 µM RGD and were
cultured in serum-free DMEM without PDGF supplement. Cells were fixed with
4% PFA, stained with 40,6-diamidino-2-phenylindole (DAPI) and visualized
with confocal and bright-field microscopy. Quantification was performed using
Fiji and Imaris software.
FXIIIa-mediated biomolecule tethering to hydrogels in two dimensions.
Laser-treated hydrogels were immersed in FXIIIa-labelling solution (5 U ml−1
FXIIIa, 50 mM CaCl2, 150 mM NaCl, and 50 mM Tris at pH 7.6) with a protein of
interest bearing a FXIII substrate. To fluorescently visualize local FXIIIa-catalysed
crosslinking, the Q-peptide was functionalized with a maleimide-functionalized
Alexa Fluor dye (A-20347, Invitrogen) through its cysteine side chain thiol.
FXIIIa-mediated fluorescent patterns were obtained on reaction with 150 µM
fluorescent Q-peptide for 45 min at room temperature. The crosslinking reaction
was stopped by adding washing buffer (100 mM NaCl and 50 mM Tris buffer, at
pH 7.6). Fluorescent patterns were visible after about 30 min of washing, the time
necessary for sufficient diffusion of non-bound fluorescent peptide. Fluorescent
microscopy images were acquired after overnight washing at 4 ◦C to ensure
complete diffusion of the soluble fluorescent peptide.
Received 1 March 2013; accepted 2 September 2013;
published online 13 October 2013
References
1. Langer, R. & Tirrell, D. A. Designing materials for biology and medicine.
Nature 428, 487–492 (2004).
2. Lutolf, M. P. & Hubbell, J. A. Synthetic biomaterials as instructive extracellular
microenvironments for morphogenesis in tissue engineering. Nature
Biotechnol. 23, 47–55 (2005).
3. Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs
stem cell lineage specification. Cell 126, 677–689 (2006).
4. Lutolf, M. P., Doyonnas, R., Havenstrite, K., Koleckar, K. & Blau, H. M.
Perturbation of single hematopoietic stem cell fates in artificial niches. Int. Biol.
1, 59–69 (2009).
5. Gilbert, P. M. et al. Substrate elasticity regulates skeletal muscle stem cell
self-renewal in culture. Science 329, 1078–1081 (2010).
6. Lee, K., Silva, E. A. & Mooney, D. J. Growth factor delivery-based tissue
engineering: General approaches and a review of recent developments.
J. R. Soc. Inter. 8, 153–170 (2011).
7. Katz, J. S. & Burdick, J. A. Light-responsive biomaterials: Development and
applications. Macromol. Biosci. 10, 339–348 (2010).
8. Kloxin, A., Kasko, A. M., Salinas, C. N. & Anseth, K. Photodegradable
hydrogels for dynamic tuning of physical and chemical properties. Science 324,
59–63 (2009).
9. Wong, D. Y., Griffin, D. R., Reed, J. & Kasko, A. M. Photodegradable
hydrogels to generate positive and negative features over multiple length scales.
Macromolecules 43, 2824–2831 (2010).
10. Ramanan, V. V. et al. Photocleavable side groups to spatially alter hydrogel
properties and cellular interactions. J. Mater. Chem. 20, 8920–8926 (2010).
11. Luo, Y. & Shoichet, M. S. A photolabile hydrogel for guided three-dimensional
cell growth and migration. Nature Mater. 3, 249–253 (2004).
12. Hahn, M., Miller, J. & West, J. Three-dimensional biochemical and
biomechanical patterning of hydrogels for guiding cell behavior. Adv. Mater.
18, 2679–2684 (2006).
VEGF patterning. FXIIIa-catalysed patterning of a VEGF121 variant comprising an
exogenous Q-peptide was performed as described above. VEGF121 (5.4 µg in 30 µl)
of FXIIIa labelling solution was added to the laser-exposed hydrogels and left for
45 min at room temperature. After overnight washing in washing buffer at 4 ◦C,
VEGF patterns were visualized by immunostaining with a VEGF-specific primary
antibody (rabbit polyclonal VEGF, A-20, sc-152, Santa Cruz Biotechnology)
followed by exposure to an Alexa Fluor 647 goat antirabbit secondary antibody
(A-21245, Invitrogen). Fluorescent microscopy images were acquired after two
hours of washing in PBS with 0.1% Tween.
ProteinA patterning. Gel modification by ProteinA was achieved in two
steps comprising functionalization of ProteinA with maleimide groups by
reacting it with a heterobifunctional PEG linker (NHS–PEG–maleimide, 5
molar excess), followed by attachment of the Q-peptide through its free
thiol. The obtained Q-peptide-modified ProteinA (19.6 µg) was added to
30 µl FXIIIa reaction buffer for subsequent ProteinA immobilization on the
laser-activated hydrogel. The reaction was conducted as described above.
Control hydrogels were treated in the same manner except for the addition
of ProteinA to FXIIIa reaction buffer. The patterns of tethered ProteinA were
visualized by immunostaining with an Alexa Fluor 488 rabbit secondary antibody
(A-11078, Invitrogen).
1077
© 2013 Macmillan Publishers Limited. All rights reserved